Also, α-mangostin treatment upregulated liver AMPK, SIRT-1 and PPARγ showing that this compound could ameliorate obesity and liver steatosis by these pathways [33]. This evidence concerns the gene SIRT1 and obesity due to melanocortin 4 receptor deficiency.